Bruker Corporation (NASDAQ:BRKR) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 26, Guggenheim analyst Subbu Nambi reiterated her Buy rating on Bruker Corporation (NASDAQ:BRKR). She revised her price target from $53 to $58, which leads to an upside potential of almost 25%. Copyright: dolgachov / 123RF Stock Photo Nambi’s target price adjustment is part of Guggenheim’s revisions to its forecasts and targets for many of the stocks within the Diagnostics and ...

投资组合表现 - 第三季度投资组合回报率为6.3%（净回报6.2%）但低于罗素1000指数8.0%的涨幅[1] - 美国股市上涨由美联储降息、稳健的企业盈利和对人工智能的热情推动[1] 布鲁克公司股票表现 - 布鲁克公司股价在第三季度收盘时为每股38.71美元 市值为58.73亿美元[2] - 该股一个月回报率为6.17% 但过去52周内价值下跌了34.78%[2] 布鲁克公司业务与市场 - 布鲁克公司专注于科学仪器以及分析和诊断解决方案的开发与制造[2] - 第二季度末有42只对冲基金持有该公司头寸 较前一季度的40只有所增加[4] 投资策略调整 - 投资组合管理人决定在第三季度清仓布鲁克公司头寸 因该股自2024年买入后表现显著弱于大盘[3] - 清仓原因包括股价触及软性止损位 且公司无内部人士买入或加速回购[3] 行业与市场环境 - 布鲁克公司面临制药支出疲软、美国国立卫生研究院和学术经费可能削减以及关税担忧等不利因素[3] - 第二季度财报表现不佳影响了市场情绪[4]